Spot Trading’s Amicus Therapeutics FOLD Stock Holding History

Spot Trading’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$149K	Buy	9,900 +900	+10%	+$11.9K	﹤0.01%	2390
2017 Q2	$91K	Sell	9,000 -6,400	-42%	-$51.5K	﹤0.01%	2632
2017 Q1	$110K	Sell	15,400 -19,600	-56%	-$124K	﹤0.01%	2218
2016 Q4	$174K	Buy	+35,000	New	+$242K	﹤0.01%	1991
2016 Q2	–	Sell	-114,400	Closed	-$967K	–	3476
2016 Q1	$967K	Buy	114,400 +67,300	+143%	+$477K	0.02%	1126
2015 Q4	$457K	Buy	47,100 +24,900	+112%	+$224K	﹤0.01%	1981
2015 Q3	$311K	Sell	22,200 -17,800	-45%	-$279K	﹤0.01%	2377
2015 Q2	$566K	Buy	40,000 +33,600	+525%	+$404K	0.01%	2033
2015 Q1	$70K	Buy	+6,400	New	+$56.4K	﹤0.01%	3212
2014 Q4	–	Sell	-44,500	Closed	-$265K	–	4136
2014 Q3	$265K	Buy	+44,500	New	+$233K	﹤0.01%	2993

Other funds holding FOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spot Trading's FOLD Position: Q3 2017 in Review

Spot Trading increased its Amicus Therapeutics (FOLD) stake by 57% in Q3 2017, buying an estimated $75.2K and bringing the position to 15,578 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Spot Trading first reported a position in FOLD in Q3 2014 and has held it in 8 quarters since. 186 funds tracked by Wall St. Rank hold FOLD as of Q3 2017.

Spot Trading held 15,578 shares of Amicus Therapeutics worth $235K as of Q3 2017.
Spot Trading bought 5,686 Amicus Therapeutics shares in Q3 2017, an estimated $75.2K.
Amicus Therapeutics made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2135 holding.
Spot Trading first reported a position in Amicus Therapeutics in Q3 2014 and has held it in 8 quarters since.
186 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.